CME Group’s Stock Climbs Above Analyst Target Price of $270.39
Recently, CME Group Inc. (Symbol: CME) shares climbed above the average analyst 12-month target price of $270.39, trading at $272.36 per share. When a stock reaches its target price, analysts typically react in one of two ways: they may downgrade based on valuation or adjust their target price upwards. The decision often hinges on company performance and market conditions; if the outlook is positive, a target price increase could be warranted.
Analyst Target Insights
The average target for CME Group Inc. incorporates input from 18 different analysts within the Zacks coverage universe. However, individual analyst targets vary significantly, with one predicting a price as low as $211.00, while another sets a target as high as $305.00. The standard deviation among these targets is $25.82.
Investor Considerations
Analyzing the average price target serves as a “wisdom of crowds” methodology, aggregating insights from multiple analysts rather than relying on a single opinion. With CME crossing the average target of $270.39, investors are prompted to reassess their positions: is this target a stepping stone toward higher prices, or is it time to consider taking profits as the valuation may be stretched?
Current Analyst Ratings for CME Group
| Recent CME Analyst Ratings Breakdown | ||||
|---|---|---|---|---|
| » | Current | 1 Month Ago | 2 Months Ago | 3 Months Ago |
| Strong Buy ratings: | 7 | 7 | 6 | 6 |
| Buy ratings: | 2 | 1 | 0 | 0 |
| Hold ratings: | 7 | 8 | 9 | 9 |
| Sell ratings: | 1 | 1 | 1 | 1 |
| Strong Sell ratings: | 2 | 2 | 2 | 2 |
| Average rating: | 2.39 | 2.47 | 2.61 | 2.61 |
The average rating listed in the table above is derived from a scale of 1 to 5, where 1 indicates a Strong Buy and 5 indicates a Strong Sell. Data sourced from Zacks Investment Research via Quandl.com provides insight into the current sentiment surrounding CME Group.
